Comprehensive Analysis of Androgen-Regulated Genes in Prostate Cancer Cells

Scientists at Imperial College London have shed new light on cancer gene therapy with their recent findings published in the journal Oncogene. The study focused on androgen-regulated genes in human LNCaP prostate cancer cells, highlighting the importance of these genes in understanding prostate cancer development and progression. The researchers used microarray coupled to quantitative RT-PCR analysis to identify androgen-regulated genes in the LNCaP cell line, revealing a significant number of genes affected by androgen treatment. This study provides valuable insights into the mechanisms of prostate cancer and potential targets for cancer gene therapy.

Key Takeaways:

• The study identified 319 genes stimulated by androgen treatment in the LNCaP cell line, with 300 genes being significantly repressed.
• Quantitative RT-PCR analysis confirmed the expression of upregulated and downregulated genes over a time-course of androgen treatment from 0 to 72 hours.
• The study highlights the importance of androgen-regulated genes in understanding prostate cancer development and progression.
• The researchers identified a number of androgen-regulated genes not previously described as candidates for mediating androgen responses in prostate cancer cells.
• The study used microarray coupled to quantitative RT-PCR analysis, a powerful tool for identifying androgen-regulated genes in prostate cancer cells.
• The researchers tested the effects of various androgen agonists and antagonists on gene expression, providing further insight into the mechanisms of prostate cancer.
• The study's findings have significant implications for cancer gene therapy, with potential targets for therapy identified among the androgen-regulated genes.

Statistics:

• 319 genes were stimulated by androgen treatment in the LNCaP cell line.
• 300 genes were significantly repressed by androgen treatment.
• Gene expression analysis was carried out over a time-course of 0 to 72 hours.
• Quantitative RT-PCR analysis was used to confirm the expression of 60 of the most robustly downregulated genes.
• The study identified a number of androgen-regulated genes not previously described as candidates for mediating androgen responses in prostate cancer cells.

Sources:

• Ngan, S., et al. (2009). Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene, 28(19), 2051-2063.
• Ngan, S. (Contact). Imperial College London, Dept. of Oncology, UK.
• Nature Publishing Group. (Publisher). 345 Park Avenue South, New York, NY 10010-1707, USA.